I am currently working with a compound which is expected to bind G-quadruplex structure in c-MYC promoter. While I observed very poor affinity between c-MYC quadruplex and the compound in vitro in Isothermal titration calorimetry, I observed significant decrease of promoter activity in c-MYC by the same drug through quadruplex binding in its promoter. The compound has quadruplex-to-duplex selectivity but fails to distinguish different quadruplexes in the cells and non-specifically binds to other oncogene and telomere quadruplex in the cells?